Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Lancet. Respiratory Medicine|September 6, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studiesPierre-Régis Burgel, Jennifer Da Silva, Emmanuelle Girodon, et al.
Respirology (Carlton, Vic.)|February 12, 2024
Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adultsRémi Diesler, Marie Legendre, Salim Si-Mohamed, et al.
The Lancet. Respiratory Medicine|August 16, 2024
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world studyPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Emmanuelle Girodon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 19, 2022
Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-GOlivier Brugière, Domitille Mouren, Julie Trichereau, et al.
The European Respiratory Journal|February 16, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del <i>CFTR</i> variantPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Isabelle Durieu, et al.
The European Respiratory Journal|September 11, 2023
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescriptionElise Dreano, Pierre Régis Burgel, Aurelie Hatton, et al.
Frontiers in Pharmacology|November 14, 2025
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTRIwona Pranke, Valeria Capurro, Benoit Chevalier, et al.
The European Respiratory Journal|November 19, 2021
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosisAlienor Campredon, Enzo Battistella, Clémence Martin, et al.
Pageof 5